Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tratamiento no farmacológico

490 ARTíCULOS , VIENDO DEL 151 AL 165

PUBMED

Effects of Hippeastrum reticulatum on memory, spatial learning and object recognition in a scopolamine-induced animal model of Alzheimer's disease

Hoang THX, Ho DV, Van Phan K, Le QV, Raal A, Nguyen HT.

Pharm Biol. 2020 Dec;58(1):1098-1104. doi: 10.1080/13880209.2020.1841810.

0

0

0

PUBMED

Apolipoprotein J in Alzheimer's Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches

Moezzi SM, Mozafari N, Fazel-Hoseini SM, Nadimi-Parashkoohi S, Abbasi H, Ashrafi H, Azadi A.

ACS Chem Neurosci. 2020 Dec 16;11(24):4060-4072. doi: 10.1021/acschemneuro.0c00637. Epub 2020 Nov 29.

0

0

0

PUBMED

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases

Hepp Rehfeldt SC, Majolo F, Goettert MI, Laufer S.

Int J Mol Sci. 2020 Dec 18;21(24):9677. doi: 10.3390/ijms21249677.

0

0

0

PUBMED

Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies

Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D.

Ageing Res Rev. 2020 Mar;58:101001. doi: 10.1016/j.arr.2019.101001. Epub 2019 Dec 20.

0

0

0

PUBMED

The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol

Kainuma M, Funakoshi K, Ouma S, Yamashita KI, Ohara T, Yoshiiwa A, Murata M, Tsuboi Y.

Medicine (Baltimore). 2020 Sep 18;99(38):e22370. doi: 10.1097/MD.0000000000022370.

0

0

0

PUBMED

Can Alzheimer's Disease Be Prevented? First Evidence from Spinal Stimulation Efficacy on Executive Functions

Pisano F, Caltagirone C, Satriano F, Perri R, Fadda L, Marangolo P.

J Alzheimers Dis. 2020;77(4):1755-1764. doi: 10.3233/JAD-200695.

0

0

0

PUBMED

NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease

Shi JQ, Wang BR, Jiang T, Gao L, Zhang YD, Xu J.

J Alzheimers Dis. 2020;77(3):923-934. doi: 10.3233/JAD-200359.

0

0

0

PUBMED

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

Hazan S.

J Int Med Res. 2020 Jun;48(6):300060520925930. doi: 10.1177/0300060520925930.

0

0

0

PUBMED

Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations

Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V.

Molecules. 2020 Nov 13;25(22):5294. doi: 10.3390/molecules25225294.

0

0

0

PUBMED

Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer's Disease: A Recent Update

Pandey M, Choudhury H, Verma RK, Chawla V, Bhattamisra SK, Gorain B, Raja MAG, Amjad MW.

CNS Neurol Disord Drug Targets. 2020;19(9):648-662. doi: 10.2174/1871527319999200819095620.

0

0

0

PUBMED

Lifestyle Risk Factors and Cognitive Outcomes from the Multidomain Dementia Risk Reduction Randomized Controlled Trial, Body Brain Life for Cognitive Decline (BBL-CD)

McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, DʼEste C, Anstey KJ.

J Am Geriatr Soc. 2020 Nov;68(11):2629-2637. doi: 10.1111/jgs.16762. Epub 2020 Sep 9.

0

0

0

PUBMED

Protocol for an embedded pragmatic clinical trial to test the effectiveness of Aliviado Dementia Care in improving quality of life for persons living with dementia and their informal caregivers

Bristol AA, Convery KA, Sotelo V, Schneider CE, Lin SY, Fletcher J, Rupper R, Galvin JE, Brody AA.

Contemp Clin Trials. 2020 Jun;93:106005. doi: 10.1016/j.cct.2020.106005. Epub 2020 Apr 19.

0

0

0

PUBMED

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

0

0

0

PUBMED

Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer's disease and chronic obstructive pulmonary disease: a retrospective observational study

Cao Y, Qian L, Yu W, Li T, Mao S, Han G.

J Int Med Res. 2020 Feb;48(2):300060520902895. doi: 10.1177/0300060520902895.

0

0

0

PUBMED

Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies

Henríquez G, Gomez A, Guerrero E, Narayan M.

ACS Chem Neurosci. 2020 Oct 7;11(19):2915-2934. doi: 10.1021/acschemneuro.0c00381. Epub 2020 Sep 11.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy